Performance of the Sofia SARS-CoV-2 Rapid Antigen Test in Symptomatic and Asymptomatic Pediatric Patients

Megan Culler Freeman1, Tanner J Freeman2, Jennifer Iagnemma3

  • 1Department of Pediatrics, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Insights

The Quidel Sofia antigen test showed high sensitivity in symptomatic children for detecting SARS-CoV-2. This antigen-detecting rapid diagnostic test (Ag-RDT) is a valuable tool for pediatric COVID-19 diagnosis.

Area of Science:

  • Pediatric Infectious Diseases
  • Diagnostic Test Evaluation
  • Virology

Background:

  • Limited data exists on the diagnostic accuracy of SARS-CoV-2 antigen tests in pediatric populations.
  • Accurate and rapid diagnostic tools are crucial for managing pediatric respiratory infections.

Purpose of the Study:

  • To evaluate the sensitivity and specificity of the Quidel Sofia SARS-CoV-2 antigen test (Sofia-Ag-RDT) in children presenting to outpatient care.
  • To compare the performance of the Sofia-Ag-RDT against a molecular benchmark test.

Main Methods:

  • A comparative diagnostic accuracy study was conducted from November 2020 to April 2021.
  • Children presenting to outpatient care were tested using the Sofia-Ag-RDT.
  • Results were compared against the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV reverse transcriptase-polymerase chain reaction (RT-PCR) test.

Main Results:

  • The Sofia-Ag-RDT demonstrated the highest sensitivity in symptomatic children, with an estimated sensitivity of 82% (95% confidence interval, 68%-91%).
  • Specificity data was also collected but not detailed in the provided abstract.

Conclusions:

  • The Quidel Sofia SARS-CoV-2 antigen test exhibits notable sensitivity for detecting SARS-CoV-2 in symptomatic children within an outpatient setting.
  • Further research may be warranted to confirm specificity and performance across diverse pediatric populations.

Related Concept Videos